Rosenblatt Securities Reiterates "Buy" Rating for Arteris (NASDAQ:AIP)

Rosenblatt Securities reissued their buy rating on shares of Arteris (NASDAQ:AIP - Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $14.00 price objective on the stock.

Separately, Northland Securities boosted their price objective on Arteris from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Wednesday, February 19th.

Arteris Trading Down 1.0%

Shares of AIP traded down $0.07 during trading hours on Wednesday, hitting $7.13. The stock had a trading volume of 135,311 shares, compared to its average volume of 201,294. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. Arteris has a 12-month low of $5.46 and a 12-month high of $12.64. The firm has a market cap of $299.30 million, a P/E ratio of -8.20 and a beta of 1.31. The company's fifty day simple moving average is $6.86 and its 200 day simple moving average is $8.63.

Insiders Place Their Bets

In related news, CEO K Charles Janac sold 7,150 shares of Arteris stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total value of $50,908.00. Following the sale, the chief executive officer now directly owns 318,117 shares in the company, valued at $2,264,993.04. This trade represents a 2.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Nicholas B. Hawkins sold 5,968 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.57, for a total transaction of $51,145.76. Following the completion of the transaction, the chief financial officer now owns 186,123 shares of the company's stock, valued at $1,595,074.11. This represents a 3.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,927 shares of company stock valued at $371,639 over the last three months. Company insiders own 29.10% of the company's stock.

Institutional Investors Weigh In On Arteris

Hedge funds have recently modified their holdings of the stock. US Bancorp DE grew its stake in Arteris by 29.0% during the 4th quarter. US Bancorp DE now owns 5,702 shares of the company's stock valued at $58,000 after acquiring an additional 1,283 shares in the last quarter. American Century Companies Inc. grew its position in Arteris by 6.0% during the fourth quarter. American Century Companies Inc. now owns 30,357 shares of the company's stock valued at $309,000 after purchasing an additional 1,731 shares in the last quarter. EntryPoint Capital LLC increased its stake in Arteris by 14.0% in the 4th quarter. EntryPoint Capital LLC now owns 19,814 shares of the company's stock valued at $202,000 after buying an additional 2,430 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Arteris by 4.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company's stock worth $802,000 after buying an additional 3,298 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of Arteris by 38.9% during the 4th quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock valued at $134,000 after buying an additional 3,694 shares during the period. 64.36% of the stock is owned by hedge funds and other institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.